Progenity Provides Results from Key Study for Its Targeted Therapeutics Program streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Researchers are developing an artificial intelligence tool for toilets that could help analyze patient stool.
The technology could give gastroenterologists the information they need to provide appropriate treatment for chronic issues such as inflammatory bowel disease and irritable bowel syndrome.
“Typically, gastroenterologists have to rely on patient self-reported information about their stool to help determine the cause of their gastrointestinal health issues, which can be very unreliable,” says Deborah Fisher, associate professor of medicine at Duke University and one of the lead authors of the study.
“Patients often can’t remember what their stool looks like or how often they have a bowel movement, which is part of the standard monitoring process,” Fisher says. “The Smart Toilet technology will allow us to gather the long-term information needed to make a more accurate and timely diagnosis of chronic gastrointestinal problems.”
Who knew you needed highly sophisticated digital technology in a plumbing fixture that collects doo-doo?
Scientists at Duke knew it, and they decided to take action for the betterment of bowel movements and the benefit of mankind.
Yes, these prolific probers for the advancement of porcelain poo-catchers are developing an artificial intelligence tool that can capture a photograph of your dirty dumplings and send it to your doctor for enjoyable viewing and analysis.
Upon completion of your fecal forensic, the doctor can then offer the most effective treatment for whatever ails your anus.
With any luck, your chronic inflammatory bowel disease (IBD) and irritable bowel syndrome (IBS) will be a thing of the past!
New Allakos Data Presented at DDW 2021 Suggest that Eosinophilic Gastritis and/or Eosinophilic Duodenitis (EG/EoD) is Highly Underdiagnosed and may be a Common Cause of Moderate-to-Severe Gastrointestinal Symptoms
45% (181/405) of patients with chronic functional gastrointestinal symptoms who underwent upper endoscopy with biopsy met the diagnostic criteria for eosinophilic gastritis and/or eosinophilic duodenitis (EG/EoD)
May 24, 2021 07:00 ET | Source: Allakos Inc. Allakos Inc. Redwood City, California, UNITED STATES
REDWOOD CITY, Calif., May 24, 2021 (GLOBE NEWSWIRE) Allakos Inc. (the “Company”) (Nasdaq: ALLK), a biotechnology company developing lirentelimab (AK002) for the treatment of eosinophil and mast cell-related diseases, reported data at Digestive Disease Week (DDW) 2021. Results from a prospective study examined the rates of elevated tissue eosinophils in patients with chronic unexplained gastrointestinal
An image analysis tool, installed in the pipes, could help prevent gastrointestinal health problems. AFP Relaxnews
American researchers have developed an artificial intelligence capable of analysing stools when they arrive in the pipes. This tool would enable better follow-up of patients suffering from intestinal disorders.
Daily stool tracking. This is the objective of a new technology presented at Digestive Disease Week® (DDW) 2021, which took place from May 21 to 23.
The analysed data could allow gastroenterologists to improve patient management.
“Typically, gastroenterologists have to rely on patient self-reported information about their stool to help determine the cause of their gastrointestinal health issues, which can be very unreliable,” explains Deborah Fisher, professor of medicine at Duke University Durham in North Carolina and a lead author on the study.